PharmaCyte Biotech (PMCB) Return on Assets [ROA] (2011 - 2026)
PharmaCyte Biotech's Return on Assets [ROA] was -15.17% in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 9.44 percentage points from -5.73% a year earlier and down 3.24 percentage points from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Return on Assets [ROA] at PharmaCyte Biotech came in at -12.01%, down 6.86 percentage points from FY2025.
- Return on Assets [ROA] shows a five-year change of +41.43 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -5.15% in FY2025 (+2.54 pp), -7.69% in FY2024 (-2.18 pp), -5.51% in FY2023 (+3.13 pp) and -8.64% in FY2022 (+44.80 pp).
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Assets [ROA] since fiscal Q1 2022.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -2.42 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q1 2023 (a gain of 48.32 percentage points); the worst was fiscal Q1 2027 (a drop of 9.44 percentage points).
- Per Business Quant data, PMCB's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was -11.93% (Q4 2026), -8.05% (Q3 2026) and -6.56% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | -15.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -15.17% |
| Apr 30, 2026 | -11.93% |
| Jan 31, 2026 | -8.05% |
| Oct 31, 2025 | -6.56% |
| Jul 31, 2025 | -5.73% |
| Apr 30, 2025 | -5.98% |
| Jan 31, 2025 | -9.24% |
| Oct 31, 2024 | -7.74% |
| Jul 31, 2024 | -7.14% |
| Apr 30, 2024 | -7.80% |
| Jan 31, 2024 | -3.84% |
| Oct 31, 2023 | -3.54% |
| Jul 31, 2023 | -5.45% |
| Apr 30, 2023 | -5.98% |
| Jan 31, 2023 | -7.19% |
| Oct 31, 2022 | -6.66% |
| Jul 31, 2022 | -5.34% |
| Apr 30, 2022 | -4.64% |
| Jan 31, 2022 | -4.18% |
| Oct 31, 2021 | -7.67% |
API Access
PharmaCyte Biotech Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();